NENCI, Giuseppe Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 2.291
AS - Asia 1.903
EU - Europa 1.786
SA - Sud America 194
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.202
Nazione #
US - Stati Uniti d'America 2.237
HK - Hong Kong 741
SG - Singapore 630
UA - Ucraina 483
IE - Irlanda 328
RU - Federazione Russa 218
CN - Cina 180
BR - Brasile 172
SE - Svezia 160
VN - Vietnam 135
DE - Germania 134
FI - Finlandia 130
IT - Italia 127
TR - Turchia 74
GB - Regno Unito 72
KR - Corea 64
FR - Francia 45
CA - Canada 33
IN - India 17
NL - Olanda 15
BE - Belgio 14
CH - Svizzera 13
PL - Polonia 13
BD - Bangladesh 12
ZA - Sudafrica 11
AR - Argentina 10
MX - Messico 10
UZ - Uzbekistan 9
JP - Giappone 8
PK - Pakistan 8
AT - Austria 5
CZ - Repubblica Ceca 5
EG - Egitto 5
GR - Grecia 5
PY - Paraguay 5
ES - Italia 4
IQ - Iraq 4
LB - Libano 4
LT - Lituania 4
BG - Bulgaria 3
ID - Indonesia 3
MY - Malesia 3
SA - Arabia Saudita 3
AM - Armenia 2
AO - Angola 2
EC - Ecuador 2
EU - Europa 2
MA - Marocco 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CU - Cuba 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
ME - Montenegro 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 6.202
Città #
Hong Kong 741
Singapore 397
Chandler 342
Dublin 328
Jacksonville 270
San Mateo 201
Boardman 113
Ashburn 105
Santa Clara 96
Dong Ket 88
Medford 84
Princeton 84
Ann Arbor 79
Altamura 72
Moscow 70
Izmir 68
Seoul 64
Wilmington 64
Andover 48
Des Moines 48
Beijing 47
Lawrence 43
Helsinki 34
Munich 33
Los Angeles 26
Piscataway 26
New York 23
Saint Petersburg 23
Shanghai 21
Ho Chi Minh City 18
The Dalles 16
Brussels 14
Ottawa 14
Norwalk 13
Perugia 13
Woodbridge 12
Turku 11
Dallas 10
São Paulo 10
Montreal 9
Denver 8
London 8
Macerata 8
Stockholm 8
Brooklyn 7
Council Bluffs 7
Den Haag 7
Frankfurt am Main 7
Houston 7
San Francisco 7
Tokyo 7
Toronto 7
Auburn Hills 6
Chennai 6
Hanoi 6
Johannesburg 6
Phoenix 6
San Paolo di Civitate 6
Belo Horizonte 5
Cairo 5
Da Nang 5
Amsterdam 4
Chicago 4
Dearborn 4
Guangzhou 4
Kraków 4
Manchester 4
Mexico City 4
Poplar 4
Rio de Janeiro 4
Ankara 3
Atlanta 3
Brasília 3
Catanduva 3
Charlotte 3
Concord 3
Curitiba 3
Orem 3
Philadelphia 3
Porto Alegre 3
Sofia 3
Viçosa 3
Aracaju 2
Asunción 2
Baghdad 2
Betim 2
Blumenau 2
Boston 2
Bắc Ninh 2
Cape Town 2
Capua 2
Casablanca 2
Casalbordino 2
Changsha 2
Ciampino 2
Ciudad del Este 2
Columbus 2
Coronel Fabriciano 2
Dhaka 2
Feira de Santana 2
Totale 4.025
Nome #
Fisiopatologia dell'emostasi 520
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 152
A case of Capnocytophaga canimorsus sepsis and suspected myocardial injury following a dog bite 143
Oral anticoagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS) 138
Absorption and antithrombotic activity of unfractioned heparin after intraduodenal administration in rats 107
Altered platelet function associated with the bronchial hyperresponsiveness accompanying nocturnal asthma 105
OAT with POC devices and remote computer monitoring in the setting of the Italian NHS: a controlled clinical trial 97
Effect of cloricromene on intermittent claudication. A randomized double-blind, placebo controlled trial in patients treated with aspirin: effect on claudication distance and quality of life 97
Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism 96
Activation of phospholipase A2 and ß-thromboglobulin release in human platelets stimulated with thrombin and fluoro aluminate 95
LMWH or Ximelagatran versus VKA in the prevention of VTE after major knee surgery: a meta-analysis of randomized controlled trials 94
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 92
Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. 92
Risk factor for upper limb deep vein thrombosis 86
Peripheral arteriopathy: effects of cloricromene on claudication and quality of life, a randomized double blind,,placebo controlled trial in patients treated with aspirin 86
Choline plasmalogen biosynthesis by transmethylation in human platelets 86
Effect of different plasma expanders on erythrocyte filterability 85
Assessment of occlusion of the vascular access in patients on chronic hemodialysis: comparison of physical examination with continuous-wave doppler ultrasound. 84
Terapia anticoagulante orale con l’impiego di tecnologia POC e monitoraggio via web nell’ambito del Sistema Sanitario Nazionale Italiano 82
Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants a case-control study 82
Differences between human platelets erythrocyte membranes.A spectroscopic study with particular refernce to IR and Laser Raman spectroscopy. 81
Profilassi della trombosi venosa profonda in neurochirurgia 78
Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. 78
Effect of pentoxifylline on platelet aggregation 78
Effect of glyceryl trinitrate on distensibility of peripheral muscular arteries in humans is not mediated by prostaglandins 78
Diagnostica generale delle malattie emorragiche. 77
Intracellular signal transduction mechanisms regulating the release of lysosomes by activated human platelets 77
Cholinephosphotransferase activity in human platelet 77
Erythocyte deformability changes in normal pregnancy and preeclampsia 76
A randomized study on eversion versus standard carotid endarterectomy: Study design and preliminary results: The EVEREST Trial 76
Kidney failure and endothelial disfunction: effects of haemodialysis 75
Characterization of N, N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets. 75
Interferon-alpha is effective in the treatment of HIV-1-related, severe, zidovudine-resistant thrombocytopenia. A prospective, placebo-controlled, double-blind trial 73
Clotting activation after blood transfusion in patients receiving 5-fluorouracil and mitomycin -C treatment 72
Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trial 70
Evaluation of the antithrombotic activity of unfractioned heparin or nadroparine after oral administration in man 69
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 68
Picotamide protects mice from death in a pulmonary embolism model by a mechanism independent from thromboxane suppression 68
Platelets release their lysosomal content in vivo in humans upon activation 67
Platelet activation and allergic asthma. 66
Pharmacoeconomic evaluation of the management of oral anticoagulant treatment with point-of-care devices in the Italian national health care system 65
Treatment of intermittent claudication with mesoglycan - a placebo-controlled, double - blind study. 65
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation 65
Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate. 65
Low molecular weight heparins prevent thrombin-induced thromboembolism in mice despite low antithrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition. 64
High shear stress induces nitric oxide synthesis in human platelets - 63
Risk factor for upper extremity deep vein thrombosis 63
Interaction beteween thrombophilic genetic mutations and clinical bleeding in patients undergoing chronic oral anticoagulant treatment 62
Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement 62
Safety and efficacy of ximelagatran: meta-analysis of the controlled randomized trials for the prophylaxis or treatment of venous thromboembolism 62
Human blood platelets release their lysosomal content ''in vivo'' at a localized site of platelet activation 62
Generation of arachidonic acid metabolites from stimulated whole blood in patients with chronic myeloproliferative disorders 62
Erythrocyte deformability in pre-eclamptic women and their newborn in the evaluation of microcirculatory impairment. 62
Inhibition of fluid phase and fibrin bound thrombin: effect of heparin, r-hirudin, PEG-rm-hirudin and a thrombin exosite inhibitor 60
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. 60
Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report 59
Ultraviolet spectra of membrane-rich human platelet particulates. Normal data and specular abnormalities in hypo- and hyper-betalipoproteinemia 59
Evidence for platelet activation in allergic asthma. 59
Prostaglandin E2 potentiates platelet aggregation by priming protein kinase C. 58
Infusion of vincristine-loaded platelets in acute ITP refractory to steroids: an alternative to splenectomy 57
Red cell deformability alterations in normal late pregnancy: possible role of plasma components 57
Vincristine-loaded platelets for autoimmune thrombocytopenic purpura 56
Thromboxane synthase inhibitors, thromboxane receptor antagonists and dual blockers in thrombotic diseases. 54
Thrombolytic therapy for thromboembolism of the vertebrobasilar artery. 54
Intrinsically defective or exhausted platelets in hairy cell leukemia? 53
Thrombolytic therapy for thromboembolism of vertebrobasilar artery. 53
Platelet glycohydrolase activities: characterization and release 52
Liquid Nitrogen Snap Frozen Saphenous Vein for Vascular Access in Dialysis 52
Heparin and local haemostasis 51
Intraoperative assessment of technical perfection in carotid endarterectomy: a prospective analysis of 1305 completion procedures 51
Platelets release lambda-granules (lysosomes) “in vivo” in humans upon activation 51
Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets. Role of adenylylcyclase up-regulation 50
Platelets release lambda-granules (lysosomes) in vivo in humans upon activation 50
La safena omologa crioconservata come accesso dialitico: valutazione biologica e clinica 50
Vinca-loaded platelets 49
The reduced erythrocyte deformability in pre-eclampsia is due to altered plasma to red blood cell interactions 48
Interactions between platelets, other cells and eicosanoids in hypertension. 47
Platelets and asthma 46
In vitro and ex vivo effect of indobufen on red blood cell deformability. 45
New pyridazinone derivatives as inhibitors of platelet aggregation. 44
Thromboxane does not play a significant role in acute, cold induced vasoconstriction in raynaud’s phenomenon 44
Ruolo del sistema emostatico nella patologia cardiovascolare. Generalità. 44
Treatment of intermittent claudication with medoglycan- a placebo-controlled, double-blind study 42
Human blood platelets release their lysosomal content “in vivo” at a localised site of platelet activation 34
Platelet glycohydrolase activities: Characterization and release 26
Totale 6.335
Categoria #
all - tutte 27.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021386 0 0 0 0 0 26 76 1 90 16 80 97
2021/2022641 9 117 18 27 20 2 6 234 5 16 71 116
2022/20231.149 96 195 26 84 83 140 0 51 417 1 34 22
2023/2024931 30 43 22 4 6 2 645 12 33 17 71 46
2024/20251.054 9 150 24 26 210 30 22 63 222 65 158 75
2025/2026944 166 100 91 268 279 40 0 0 0 0 0 0
Totale 6.335